- Home
- DERM vs TSI Comparison
DERM vs TSI Comparison
Compare DERM & TSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DERM | TSI |
|---|---|---|
| Founded | 2014 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.4M | 221.7M |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | DERM | TSI |
|---|---|---|
| Price | $8.19 | $4.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $12.67 | N/A |
| AVG Volume (30 Days) | 98.1K | ★ 333.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.46% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $56,134,000.00 | N/A |
| Revenue This Year | $17.48 | N/A |
| Revenue Next Year | $55.83 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.99 | $4.57 |
| 52 Week High | $9.56 | $5.06 |
Technical Indicators
Market Signals| Indicator | DERM | TSI |
|---|---|---|
| Relative Strength Index (RSI) | 49.49 | 40.62 |
| Support Level | $6.92 | $4.58 |
| Resistance Level | $8.71 | $4.70 |
| Average True Range (ATR) | 0.43 | 0.05 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 36.20 | 51.30 |
Price Performance
Historical ComparisonAbout DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About TSI TCW Strategic Income Fund Inc.
Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment and others.